AGP Executive Report
Last update: 9 hours agoCBD Clinical Research: A randomized, placebo-controlled trial in Brazil found CBD-dominant cannabis extracts reduced pain and improved quality of life for burning mouth syndrome patients, with no adverse effects reported. CBD & Wellness Claims: A review on restless leg syndrome reports “cautious optimism” that cannabis and cannabinoids may help, especially for refractory cases, but calls for larger trials. Public Health & Harm Reduction: A coroner in Geelong is urging a safe injecting room as fatal overdoses surge, while Rhode Island’s overdose awareness push notes deaths may be down but stimulant-related overdoses and youth cannabis use remain concerns. Medical Cannabis Access: Kentucky says its medical cannabis dispensary rollout is past the halfway mark, with dozens of businesses open and thousands of cardholders. Cannabis Use Disorder: New JAMA Psychiatry data links rising cannabis use and cannabis use disorder from 2021–2024, especially among men and women. Policy Watch: Virginia hemp businesses are asking lawmakers for a hearing over new THC product limits that they say harm small operators.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
